ElectroCore CEO and leadership

Dr. Staats, a co-founder of electroCore, has been on the board of electroCore since its inception. He was the founder of the Division of Pain Medicine at Johns Hopkins University, where he was the director for 10 years. Dr. Staats is internationally recognized for his work in developing and implementing minimally invasive procedures for chronic pain, and his patents have led to the use of novel pharmacologic agents (Qutenza patch).

Dr. Staats received his medical degree from the University of Michigan Medical School in Ann Arbor and completed his residency and fellowship training at the Johns Hopkins University School of Medicine. He is a past President of the North American Neuromodulation Society, American Society of Interventional Pain Physicians, New Jersey Society of Interventional Pain Physicians, and the Southern Pain Society. He is currently Chairman of the Board of Examination of the World Institute of Pain and continues to serve as Chief Medical Officer for National Spine and Pain Centers, the largest pain practice in the United States.

Dr. Staats has written or co-edited 10 books and over 400 articles, abstracts, monographs, and book chapters on pain medicine in publications that include the Journal of the American Medicine Association, Pain, Anesthesiology, and the Journal of Clinical Oncology. His work has been highlighted on Good Morning America, CBS Evening News, Newsweek, and CNN. He has lectured extensively nationally and internationally. He has received numerous awards including physician of the year from the New York, New Jersey, and West Virginia branches of the American Society of Interventional Pain Physicians; Best Doctors in America, Top Doctors, and New Jersey Top Doctor; and the Raj Award for Excellence from the American Society of Interventional Pain Physicians.

JP received his undergraduate degree in aeronautical engineering from the Massachusetts Institute of Technology, and worked at the Air Force National Laboratory, Lincoln Laboratories. He holds both law and mechanical/materials engineering graduate degrees from Duke University.

JP trained as a patent attorney in New York, and is the author of a treatise on international intellectual property law. Along with fellow investor and Board Member, Dr. Thomas Errico, Mr. Errico has founded a number of medical device companies, including Fastenetix, K2 Medical, AD-4 Pharma, E2, and SpineCore. Products conceived by these companies have generated more than $8 billion in sales to date.

He served as the CEO of SpineCore from the inception of the company through to its sale to Stryker in July 2004.

JP is a named inventor on more than 125 issued US patents, and is a named inventor on more than 100 pending US applications. Additional patents and patent applications outside the US on which he is a named inventor number greater than 200. In addition to his current role as a Board Member, he continues also to make significant inventive contributions in all aspects of the company’s key patent portfolios, along with the clinical and market validations of the company’s products and their indications.

In 2018, Mr. Errico joined the Board of Directors of Morphogenesis, Inc., clinical-stage cell and gene therapy company with a novel platform technology in the immune-oncology field. In 2019, Mr. Errico further agreed to serve as Chief Strategy and Investment Advisor for the company.

Brian Posner is a strategic and financial leader with more than 25 years of diversified management experience, working in both public and private companies ranging from startup to $1B in revenue. Most recently he served as CFO of Ocean Power Technologies, Inc., a pioneer in wave-energy technology. Prior to that appointment, he served as CFO of Power Medical Interventions, Inc. until its sale to Covidien plc in 2009. He earlier served as CFO of Pharmacopeia, Inc. and Phytomedics, Inc., and as Regional CFO of Omnicare, Inc. Mr. Posner is a Certified Public Accountant and earned an MBA in Managerial Accounting from Pace University’s Lubin School of Business and a BA in Accounting from Queens College.

Dr. Staats, a co-founder of electroCore, has been on the board of electroCore since its inception. He was the founder of the Division of Pain Medicine at Johns Hopkins University, where he was the director for 10 years. Dr. Staats is internationally recognized for his work in developing and implementing minimally invasive procedures for chronic pain, and his patents have led to the use of novel pharmacologic agents (Qutenza patch).

Dr. Staats received his medical degree from the University of Michigan Medical School in Ann Arbor and completed his residency and fellowship training at the Johns Hopkins University School of Medicine. He is a past President of the North American Neuromodulation Society, American Society of Interventional Pain Physicians, New Jersey Society of Interventional Pain Physicians, and the Southern Pain Society. He is currently Chairman of the Board of Examination of the World Institute of Pain and continues to serve as Chief Medical Officer for National Spine and Pain Centers, the largest pain practice in the United States.

Dr. Staats has written or co-edited 10 books and over 400 articles, abstracts, monographs, and book chapters on pain medicine in publications that include the Journal of the American Medicine Association, Pain, Anesthesiology, and the Journal of Clinical Oncology. His work has been highlighted on Good Morning America, CBS Evening News, Newsweek, and CNN. He has lectured extensively nationally and internationally. He has received numerous awards including physician of the year from the New York, New Jersey, and West Virginia branches of the American Society of Interventional Pain Physicians; Best Doctors in America, Top Doctors, and New Jersey Top Doctor; and the Raj Award for Excellence from the American Society of Interventional Pain Physicians.

JP received his undergraduate degree in aeronautical engineering from the Massachusetts Institute of Technology, and worked at the Air Force National Laboratory, Lincoln Laboratories. He holds both law and mechanical/materials engineering graduate degrees from Duke University.

JP trained as a patent attorney in New York, and is the author of a treatise on international intellectual property law. Along with fellow investor and Board Member, Dr. Thomas Errico, Mr. Errico has founded a number of medical device companies, including Fastenetix, K2 Medical, AD-4 Pharma, E2, and SpineCore. Products conceived by these companies have generated more than $8 billion in sales to date.

He served as the CEO of SpineCore from the inception of the company through to its sale to Stryker in July 2004.

JP is a named inventor on more than 125 issued US patents, and is a named inventor on more than 100 pending US applications. Additional patents and patent applications outside the US on which he is a named inventor number greater than 200. In addition to his current role as a Board Member, he continues also to make significant inventive contributions in all aspects of the company’s key patent portfolios, along with the clinical and market validations of the company’s products and their indications.

In 2018, Mr. Errico joined the Board of Directors of Morphogenesis, Inc., clinical-stage cell and gene therapy company with a novel platform technology in the immune-oncology field. In 2019, Mr. Errico further agreed to serve as Chief Strategy and Investment Advisor for the company.

JP received his undergraduate degree in aeronautical engineering from the Massachusetts Institute of Technology, and worked at the Air Force National Laboratory, Lincoln Laboratories. He holds both law and mechanical/materials engineering graduate degrees from Duke University.

JP trained as a patent attorney in New York, and is the author of a treatise on international intellectual property law. Along with fellow investor and Board Member, Dr. Thomas Errico, Mr. Errico has founded a number of medical device companies, including Fastenetix, K2 Medical, AD-4 Pharma, E2, and SpineCore. Products conceived by these companies have generated more than $8 billion in sales to date.

He served as the CEO of SpineCore from the inception of the company through to its sale to Stryker in July 2004.

JP is a named inventor on more than 125 issued US patents, and is a named inventor on more than 100 pending US applications. Additional patents and patent applications outside the US on which he is a named inventor number greater than 200. In addition to his current role as a Board Member, he continues also to make significant inventive contributions in all aspects of the company’s key patent portfolios, along with the clinical and market validations of the company’s products and their indications.

In 2018, Mr. Errico joined the Board of Directors of Morphogenesis, Inc., clinical-stage cell and gene therapy company with a novel platform technology in the immune-oncology field. In 2019, Mr. Errico further agreed to serve as Chief Strategy and Investment Advisor for the company.